Analysis of enriched rare variants in JPH2-encoded junctophilin-2 among Greater Middle Eastern individuals reveals a novel homozygous variant associated with neonatal dilated cardiomyopathy
Edward G. Jones(Baylor College of Medicine), Andrew P. Landstrom(Centers for Disease Control and Prevention), Hamid Galehdari(Shahid Chamran University of Ahvaz), Hugh D. Allen(Nationwide Children's Hospital), Alireza Sedaghat(Ahvaz Jundishapur University of Medical Sciences), Yalda Jamshidi(St George's, University of London), Neda Mazaheri(Shahid Chamran University of Ahvaz), Reza Maroofian(National Hospital for Neurology and Neurosurgery), Gholamreza Shariati(Ahvaz Jundishapur University of Medical Sciences), Xander H.T. Wehrens(Baylor College of Medicine), Tahereh Seifi(Shahid Chamran University of Ahvaz), Mina Zamani(Shahid Chamran University of Ahvaz)
Cited by 34
Related Papers
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
|Nature Genetics|2007|702
Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia
|The American Journal of Human Genetics|2019|263
Disrupted Junctional Membrane Complexes and Hyperactive Ryanodine Receptors After Acute Junctophilin Knockdown in Mice
|Circulation|2011|258
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|249